New drug trial targets Hard-to-Treat liver virus
NCT ID NCT07096193
Summary
This study is testing a new drug called GS-4321 for people with chronic hepatitis delta, a serious liver infection. First, researchers will check the drug's safety and how it moves through the body in healthy volunteers. Then, they will give it to people with the disease to see if it safely lowers the amount of virus in their blood and improves liver health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS DELTA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IMSP Spitalul Clinic de Boli Infectioase "Toma Ciorba"
RECRUITINGChinsinau, 2004, Moldova
-
Investigative Site
RECRUITINGAnaheim, California, 92801, United States
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
RECRUITINGKaohsiung City, 807, Taiwan
-
Korea University Ansan Hospital
RECRUITINGAnsan-si, 425-707, South Korea
-
PMSI Clinical Republican Hospital "Timofei Mosneaga"
RECRUITINGChisinau, MD-2025, Moldova
-
Samsung Medical Center
RECRUITINGSeoul, 135-710, South Korea
-
The Catholic University of Korea Bucheon St. Mary's Hospital
RECRUITINGBucheon-si, 14647, South Korea
-
The Catholic University of Korea, Seoul St. Mary's Hospital
RECRUITINGSeoul, 06591, South Korea
Conditions
Explore the condition pages connected to this study.